Cargando…
Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragility
Osteoporosis affects one in every five women over the age of 50 worldwide. With a rapidly ageing population, the prevalence of fragility fractures, considered a largely preventable consequence of osteoporosis, is expected to increase. Age is also a major risk for cardiovascular disease and mortality...
Autores principales: | Kittithaworn, Annop, Toro-Tobon, David, Sfeir, Jad G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159251/ https://www.ncbi.nlm.nih.gov/pubmed/37129172 http://dx.doi.org/10.1177/17455057231170059 |
Ejemplares similares
-
From fragility to resilience: Advancing early identification and management of osteoporosis in post-menopausal women
por: Suvvari, Tarun Kumar, et al.
Publicado: (2023) -
Association between vitamin D and cardiovascular health: Myth or Fact? A narrative review of the evidence
por: Ahmadieh, Hala, et al.
Publicado: (2023) -
Skeletal consequences of heart failure
por: Bandeira, Francisco, et al.
Publicado: (2022) -
Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
por: Lim, Sian Yik
Publicado: (2022) -
Cardiovascular disease and bone health in aging female rheumatic
disease populations: A review
por: Cabling, Marven G, et al.
Publicado: (2023)